tradingkey.logo
tradingkey.logo
Search

Teva Pharmaceutical Industries Ltd

TEVA
Add to Watchlist
35.730USD
-0.280-0.78%
Close 05/08, 16:00ETQuotes delayed by 15 min
42.37BMarket Cap
29.01P/E TTM

Teva Pharmaceutical Industries Ltd

35.730
-0.280-0.78%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.78%

5 Days

+2.23%

1 Month

+17.07%

6 Months

+49.06%

Year to Date

+14.48%

1 Year

+97.73%

Key Insights

Teva Pharmaceutical Industries Ltd's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 156 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 40.79.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Teva Pharmaceutical Industries Ltd's Score

Industry at a Glance

Industry Ranking
28 / 156
Overall Ranking
97 / 4494
Industry
Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative-

Teva Pharmaceutical Industries Ltd Highlights

StrengthsRisks
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 29.01, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 695.47M shares, decreasing 0.95% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 13.30K shares of this stock.

Analyst Rating

Based on 13 analysts
Buy
Current Rating
40.789
Target Price
+15.39%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Teva Pharmaceutical Industries Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Teva Pharmaceutical Industries Ltd Info

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Ticker SymbolTEVA
CompanyTeva Pharmaceutical Industries Ltd
CEOFrancis (Richard D)
Websitehttps://www.tevapharm.com/
KeyAI